- Home
- ATNI vs HQL Comparison
ATNI vs HQL Comparison
Compare ATNI & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNI
- HQL
- Stock Information
- Founded
- ATNI 1987
- HQL 1992
- Country
- ATNI United States
- HQL United States
- Employees
- ATNI N/A
- HQL N/A
- Industry
- ATNI Telecommunications Equipment
- HQL Investment Managers
- Sector
- ATNI Telecommunications
- HQL Finance
- Exchange
- ATNI Nasdaq
- HQL Nasdaq
- Market Cap
- ATNI 312.7M
- HQL 368.7M
- IPO Year
- ATNI 1991
- HQL N/A
- Fundamental
- Price
- ATNI $17.30
- HQL $12.50
- Analyst Decision
- ATNI Strong Buy
- HQL
- Analyst Count
- ATNI 2
- HQL 0
- Target Price
- ATNI $31.00
- HQL N/A
- AVG Volume (30 Days)
- ATNI 57.5K
- HQL 120.9K
- Earning Date
- ATNI 04-30-2025
- HQL 01-01-0001
- Dividend Yield
- ATNI 5.62%
- HQL 11.56%
- EPS Growth
- ATNI N/A
- HQL N/A
- EPS
- ATNI N/A
- HQL 0.79
- Revenue
- ATNI $729,075,000.00
- HQL N/A
- Revenue This Year
- ATNI $1.85
- HQL N/A
- Revenue Next Year
- ATNI $1.51
- HQL N/A
- P/E Ratio
- ATNI N/A
- HQL $17.08
- Revenue Growth
- ATNI N/A
- HQL N/A
- 52 Week Low
- ATNI $14.74
- HQL $11.34
- 52 Week High
- ATNI $33.72
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- ATNI 37.82
- HQL 54.84
- Support Level
- ATNI $17.41
- HQL $11.59
- Resistance Level
- ATNI $18.10
- HQL $11.93
- Average True Range (ATR)
- ATNI 0.89
- HQL 0.38
- MACD
- ATNI -0.09
- HQL 0.17
- Stochastic Oscillator
- ATNI 18.95
- HQL 93.75
About ATNI ATN International Inc.
ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise U.S. Telecom and International Telecom. The company earns revenue from its International telecommunication segment.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.